Science. 1990 Sep 28;249(4976):1533-44.

Molecular targets for AIDS therapy.

Source

National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

Abstract

The development of antiretroviral therapy against acquired immunodeficiency syndrome (AIDS) has been an intense research effort since the discovery of the causative agent, human immunodeficiency virus (HIV). A large array of drugs and biologic substances can inhibit HIV replication in vitro. Nucleoside analogs--particularly those belonging to the dideoxynucleoside family--can inhibit reverse transcriptase after anabolic phosphorylation. 3'-Azido-2',3'-dideoxythymidine (AZT) was the first such drug tested in individuals with AIDS, and considerable knowledge of structure-activity relations has emerged for this class of drugs. However, virtually every step in the replication of HIV could serve as a target for a new therapeutic intervention. In the future, non-nucleoside-type drugs will likely become more important in the experimental therapy of AIDS, and antiretroviral therapy will exert major effects against the morbidity and mortality caused by HIV.

PMID:: 1699273; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Review Targeted therapy of human immunodeficiency virus-related disease. [FASEB J. 1991]
Review Targeted therapy of human immunodeficiency virus-related disease.
Mitsuya H, Yarchoan R, Kageyama S, Broder S. FASEB J. 1991 Jul; 5(10):2369-81.
Review NIH conference. Antiretroviral therapy in AIDS. [Ann Intern Med. 1990]
Review NIH conference. Antiretroviral therapy in AIDS.
Broder S, Mitsuya H, Yarchoan R, Pavlakis GN. Ann Intern Med. 1990 Oct 15; 113(8):604-18.
Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity. [Leukemia. 1995]
Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS, Fliakas-Boltz V, Bader JP, Buckheit RW Jr. Leukemia. 1995 Oct; 9 Suppl 1:S75-85.
Review Targets for antiviral therapy of human immunodeficiency virus infection. [J Infect. 1989]
Review Targets for antiviral therapy of human immunodeficiency virus infection.
Jeffries DJ. J Infect. 1989 Jan; 18 Suppl 1:5-13.
Review Antiretroviral chemotherapy of human immunodeficiency virus infections other than with azidothymidine. [Arch Intern Med. 1992]
Review Antiretroviral chemotherapy of human immunodeficiency virus infections other than with azidothymidine.
Sachs MK. Arch Intern Med. 1992 Mar; 152(3):485-501.

See reviews... See all...

Cited by 71 PubMed Central articles

Docking study of HIV-1 reverse transcriptase with phytochemicals. [Bioinformation. 2011]
Docking study of HIV-1 reverse transcriptase with phytochemicals.
Seal A, Aykkal R, Babu RO, Ghosh M. Bioinformation. 2011 Feb 15; 5(10):430-9. Epub 2011 Feb 15.
Synthesis of some novel annulated pyrido[2,3-d]pyrimidines via stereoselective intramolecular hetero Diels-Alder reactions of 1-oxa-1,3-butadienes. [Beilstein J Org Chem. 2010]
Synthesis of some novel annulated pyrido[2,3-d]pyrimidines via stereoselective intramolecular hetero Diels-Alder reactions of 1-oxa-1,3-butadienes.
Deb ML, Bhuyan PJ. Beilstein J Org Chem. 2010 Feb 4; 6:11. Epub 2010 Feb 4.
Review The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. [Antiviral Res. 2010]
Review The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.
Broder S. Antiviral Res. 2010 Jan; 85(1):1-18. Epub 2009 Dec 16.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Molecular targets for AIDS therapy.
Molecular targets for AIDS therapy.
Science. 1990 Sep 28 ;249(4976):1533-44.

PubMed
HIV resistance to reverse transcriptase inhibitors.
HIV resistance to reverse transcriptase inhibitors.
Biochem Pharmacol. 1994 Jan 20 ;47(2):155-69.

PubMed
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infe...
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
Proc Natl Acad Sci U S A. 1985 Oct ;82(20):7096-100.

PubMed
Hypogeusia, dysgeusia, hyposmia, and dysosmia following influenza-like infection...
Hypogeusia, dysgeusia, hyposmia, and dysosmia following influenza-like infection.
Ann Otol Rhinol Laryngol. 1975 Sep-Oct ;84(5 Pt 1):672-82.

PubMed
Facial attractiveness judgements reflect learning of parental age characteristic...
Facial attractiveness judgements reflect learning of parental age characteristics.
Proc Biol Sci. 2002 May 7; 269(1494): 873-880.

PMC

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: